Related Experiment Video
Updated: Jun 10, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Bovine colostrum in the management of nonorganic failure to thrive: a randomized clinical trial
Yunes Panahi1, Gholamhossein Falahi, Morteza Falahpour
1Research Center of Chemical Injuries, Baqiyatallah Medical Sciences University, Tehran, Iran. yunespanahi@yahoo.com
Insights
Oral bovine colostrum supplementation effectively improved weight gain in children with nonorganic failure to thrive (FTT). This 3-month intervention showed significant positive outcomes without reported side effects, offering a valuable addition to standard FTT management.
Area of Science:
- Pediatrics
- Nutritional Science
- Clinical Research
Background:
- Nonorganic failure to thrive (FTT) affects children's growth and development.
- Effective management strategies for FTT are crucial for pediatric health.
- Oral bovine colostrum is explored as a potential therapeutic agent.
Purpose of the Study:
- To assess the clinical efficacy of oral bovine colostrum in managing nonorganic FTT in children.
- To determine if bovine colostrum supplementation improves anthropometric indices in FTT patients.
- To evaluate the safety and effectiveness of bovine colostrum as an adjunct therapy.
Main Methods:
- A randomized clinical trial involving 120 children (1-10 years) with mild to moderate nonorganic FTT.
- Participants were assigned to a control group (routine care) or a case group (routine care plus bovine colostrum 40 mg/kg/day for 3 months).
- Growth was assessed using Gomez (weight for age) and Waterlow I (height for age) indices.
Main Results:
- The bovine colostrum group showed a significantly higher mean Gomez index (81.72 vs 77.12, P=0.003) after 3 months.
- A significantly greater proportion of children in the colostrum group achieved healthy status based on the Gomez index (20% vs 3.3%, P=0.006).
- No significant difference was observed in the Waterlow I index between groups (P=0.094).
Conclusions:
- Oral bovine colostrum supplementation is a safe and effective adjunct therapy for increasing weight in children with nonorganic FTT.
- The 3-month supplementation period demonstrated significant improvements in weight gain.
- Bovine colostrum offers a beneficial, side-effect-free option to enhance standard FTT treatments.
Objective:
The objective of the study was to evaluate the clinical efficacy of oral bovine colostrum in the management of nonorganic failure to thrive (FTT).
Materials And Methods:
In a randomized clinical trial, 120 children (1-10 years of age) of either sex with mild or moderate nonorganic FTT were divided into 2 groups. Both groups were matched with regard to age, sex, weight, and height. One group (control) received routine treatments for FTT and the other group (case), besides routine treatments, received supplementary bovine colostrum at the dose of 40 mg . kg . day for a 3-month period. Following the initial visit, subsequent visits were completed following 1, 2, and 3 months of supplementation. For quantitative measurements, Waterlow I (height for age) and Gomez (weight for age) indices were used.
Results:
The mean value of Gomez index in the case group (81.72) was significantly higher than the control group (77.12) at the end of the third month of supplementation (P = 0.003). Such a difference was not reported based on Waterlow I index between the case and control groups (92.91 vs 91.71; P = 0.094). According to Gomez index 12 patients (20%) who received colostrum became healthy at the end of the third month, which was significantly higher than the control group (2 cases, 3.3%); P = 0.006.
Conclusions:
Bovine colostrum supplementation for a 3-month period is a useful method without any side effects, in addition to known medical and psychological treatments, to increase the weight of children with nonorganic FTT.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Acute Pancreatitis II: Clinical Manifestations and Management
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Bioavailability Study Design: Single Versus Multiple Dose Studies
Chronic Pancreatitis II: Collaborative Care
Assessment: